Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Michelle Bradbury
Sloan Kettering Inst Can Research, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Claymore Nanotechnologies LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
NA
Renally Excreted Multimodal Core-Shell Silica Nanoparticles as Tumor-Selective Ra
Metastatic melanoma, one of the fastest rising cancers in the United States, has a very poor prognosis, and offers very few treatment options. We propose the optimization of chemical surface designs for an FDA IND approved, melanoma-targeting nanoparticle probe which can be used for combined PET and optical imaging. These multifunctional particles represent a novel tool for the disease detection, staging, targeted radiotherapy, and improved clinical outcome of human metastatic melanoma.
Filed on May 13, 2013.
Tell us what you know about Michelle Bradbury's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Michelle Bradbury filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Michelle Bradbury | Sloan Kettering Inst Can Research | Conflict of Interest | Elucida Oncology, Inc. | $0 - $4,999 |
| Michelle Bradbury | Sloan Kettering Inst Can Research | Conflict of Interest | Elucida Oncology, Inc. | $0 - $4,999 |
| Michelle Bradbury | Sloan Kettering Inst Can Research | Conflict of Interest | Claymore Nanotechnologies LLC | $0 - $4,999 |
| Michelle Bradbury | Sloan Kettering Inst Can Research | Conflict of Interest | Claymore Technologies, Inc. | $0 - $4,999 |
| Michelle Bradbury | Sloan Kettering Inst Can Research | Conflict of Interest | Claymore Technologies, Inc. | Value cannot be readily determined |
| Michelle Bradbury | Sloan Kettering Inst Can Research | Conflict of Interest | Elucida Oncology, Inc. | Value cannot be readily determined |
| Michelle Bradbury | Sloan Kettering Inst Can Research | Conflict of Interest | Elucida Oncology, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.